An article in the September/October 2015 issue of Hair Transplant Forum International highlighted results of a 6-month study of platelet rich plasma (PRP) treatment in a 23-year-old male diagnosed with androgenetic alopecia (common male pattern baldness). The study showed a significant increase in hair density and decrease in miniaturized follicles, as well as an apparent darkening of hair pigmentation.
Research published in the online edition of the journal STEM CELLS: Translational Medicine has found that Platelet-Rich Plasma therapy (PRP) may boost hair regrowth in people with androgenetic alopecia (common hair loss). Previous studies have shown that PRP has the potential to reverse hair loss, but these were limited by a short duration of study. This is the first published research showing the long-term efficacy of PRP therapy for hair loss.
Evidence that PRP may help to reverse male and female pattern baldness was found in a pilot study published in Dermatologic Surgery. In this study, researchers observed at least some noticeable improvement in 64 patients with androgenetic alopecia. Moreover, 47% of those patients experienced at least moderate to very good improvement, a level that the researchers defined as “clinically important.”
Growth factors in platelet-rich plasma (PRP) have been used to facilitate wound healing, but recently, studies have suggested that PRP may also serve as a safe and effective treatment option for male and female pattern hair loss. A recently published study in the journal BioMed Research International found that treatments of platelet-rich plasma stimulated hair growth in 10 males with pattern hair loss (androgenetic alopecia).
Research published in the Journal of the European Academy of Dermatology and Venereology found that autologous platelet-rich plasma (PRP) preparations containing CD34+ cells might be an effective treatment for male and female pattern hair loss.